IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Vantage Consulting Group Inc

Q1 2025 Holdings

Filed 2025-05-09 | 4 holdings | $5.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Cibus, Inc.(CBUS)COM17166A101$2.1M1,143,94942.6%
Babcock & Wilcox Enterprises Inc.(BW)COM05614L209$1.6M2,416,20032.3%
ADC Therapeutics SA(ADCT)COMH0036K147$1.2M850,73723.9%
Fibrogen, Inc(FGENEUR)COM31572Q808$60.7K195,7071.2%